LP Building Solutions (LP), one of the leading manufacturers of high-performance building products, on June 1st announced that Executive Vice President and Chief Financial Officer (CFO) Alan Haughie plans to retire and that Aaron Howald has been appointed as his successor, effective September 1, 2026.
To ensure a seamless transition and continuity through the completion of the company’s 2026 Annual Report process, Haughie will serve in an advisory capacity through February 2027.
“Alan has been an exceptional leader and partner during a period of important transformation for LP,” said Chief Executive Officer Jason Ringblom. “We are deeply grateful for his contributions, particularly his leadership in establishing our disciplined capital allocation strategy and building a high-performing finance organisation. We appreciate his continued support during this transition period.”
Haughie joined LP in 2019 as Executive Vice President and CFO after a distinguished career spanning public accounting, manufacturing, and business services.
Howald joined LP 15 years ago and has held leadership positions across continuous improvement, corporate finance, business development, investor relations, and financial planning and analysis. Most recently, he has served as Vice President, Investor Relations and Business Development. Prior to joining LP, he was a Senior Manager with The Thomas Group, a management consulting firm. He earned an MBA from the Indiana University Kelley School of Business and a Bachelor of Arts in Finance and Economics from Franklin College.
“Aaron is a highly respected leader with deep knowledge of our business, strategy, and financial operations,” said Ringblom. “Over the past 15 years, he has made significant contributions across multiple areas of the company and has helped strengthen our relationships with investors and analysts. Having worked closely with Alan for many years, he is exceptionally well prepared to assume the CFO role and help lead the company’s next chapter of growth.”
More related news:
Chiesi Group Names New Chair and Vice Chair
ATB Therapeutics Names Mark Throsby CEO to Drive Next Growth Phase
